Irregular interference in immunoassay
Abstract
Immune tests that allow rapid measurement of analyte parameters can be of vital importance for the correct diagnosis of a wide range of diseases. Usually, immune technologies are reliable, but they remain vulnerable to irregular analytic errors that can seriously affect the treatment of patients. Erroneous results can occur unexpectedly with respect to any sample, however now ways of identifying samples in which problems with the reliability of the results can arise are being developed. Informing clinicians of the causes of atypical interference; transfer of information about prescription and non-prescription drugs taken by patients to the laboratory; discussion of situations when laboratory results do not coincide with the clinical picture with the participation of laboratory staff - those are the key links for minimizing irregular interference.
About the Authors
V. L. Emanuel
First State Medical University n.a. I. P. Pavlov
Russian Federation
Russian Federation
V. S. Berestovskaya
First State Medical University n.a. I. P. Pavlov
Russian Federation
Russian Federation
References
1. О. А. Клименкова, В. С. Берестовская, Г. А. Иванов, А. В. Эмануэль Опыт применения индекса гемолиза как индикатора преаналитического качества для иммунохимических исследований. Вестник Росздравнадзора, 2014.- № 3.- С. 33-38.
2. Barbesino G. Misdiagnosis of Graves’ Disease with Apparent Severe Hyperthyroidism in a Patient Taking Biotin Megadoses. Thyroid. 2016; 26 (6): 860-863.
3. Grimsey P., Frey N., Bendig G., Zitzler J., Lorenz O., Kasapic D., Zaugg Ch.E. Population pharmacokinetics of exogenous biotin and the relationship between biotin serum levels and in vitro immunoassay interference. Int. J. Pharmacokinet. 2017; 2 (4): 247-256.
4. Kummer S., Hermsen D., Distelmaier F. Biotin Treatment Mimicking Graves’ Disease. N Engl J Med. 2016; 375 (7): 704-706.
5. Madden M. M., DeBias D., Cook G. E. Market analysis of vitamin supplementation in infants and children: evidence from the dietary supplement label database. JAMA Pediatr. 2014; 168 (3): 291-292.
6. Plebani M. Quality in laboratory medicine: 50 years on. Clinical Biochemistry. 2017; 50: 101-104.
7. Plebani M. Analytical quality: an unfinished journey. Clin Chem Lab Med. 2018; 56 (3): 357-359.
8. Rautiainen S., Manson JE et al. Dietary supplements and disease prevention -- a global overview. Nat Rev Endocrinol. 2016; 2 (7): 407-420.
9. Sturgeon C. M., Viljoen A. Analytical error and interference in immunoassay: minimizing risk. Ann Clin Biochem. 2011; 48 (Pt 5): 418-432.
10. Vogeser M., Seger Ch. Irregular analytical errors in diagnostic testing - a novel concept. Clin Chem Lab Med. 2018; 56 (3): 386-396.
Review
For citations:
Emanuel V.L., Berestovskaya V.S. Irregular interference in immunoassay. Medical alphabet. 2018;1(5):54-58. (In Russ.)
Views:
298
Email this article 